T7	Subject 64 175	a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations
T8	Treatment 33 60;107 119	tacrolimus and lansoprazole voriconazole
T9	Sub-Disorder 134 175	CYP2C19 and CYP3A5 heterozygous mutations
T10	Effect 0 24	Hepatic drug interaction
T12	Treat-Disorder 66 88	bone marrow transplant
T13	Drug 33 43	tacrolimus
T14	Drug 48 60	lansoprazole
T16	Drug 107 119	voriconazole
T11	Adverse_event 25 32	between
T15	Combination 44 47	and
E1	Adverse_event:T11 
E2	Combination:T15 arg:T13 arg2:T14 arg3:T16
